BLOOD 2023: Zanubrutinib Demonstrates Greater Improvements in Health-Related Quality of Life Than Ibrutinib in Waldenström Macroglobulinemia
Adherence rates were high with both drugs
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.